miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury

American Journal of Pathology

Volumn 187, Issue 1, 2017, Pages 70-79

  Wilflingseder, Julia ^a   Jelencsics, Kíra ^a   Bergmeister, Helga ^a   Sunzenauer, Judith ^a   Regele, Heinz ^a   Eskandary, Farsad ^a   Reindl Schwaighofer, Roman ^a   Kainz, Alexander ^a   Oberbauer, Rainer ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CREATININE; CYCLIN D2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KCNJ10 PROTEIN; MESSENGER RNA; MICRORNA 182; NITROGEN; PROTEIN; UNCLASSIFIED DRUG; UREA; MICRORNA; MIRN182 MICRORNA, RAT;

ACUTE KIDNEY FAILURE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; ARTICLE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOPSY; C57BL MOUSE; CELL CULTURE; DISEASE COURSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; KIDNEY; METABOLISM; PATHOLOGY; PIG; REPERFUSION INJURY; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; BIOPSY; CELLS, CULTURED; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; ISCHEMIA; KIDNEY; MALE; MICE, INBRED C57BL; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; SUS SCROFA;

EID: 85006337587     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.09.011     Document Type: Article

References (41)

1. 1 Heinze, G., Collins, S., Benedict, M.A., Nguyen, L.L., Kramar, R., Winkelmayer, W.C., Haas, M., Kainz, A., Oberbauer, R., The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival. Transplantation 82 (2006), 1441–1448.
2. 2 Hauser, P., Schwarz, C., Mitterbauer, C., Regele, H.M., Muhlbacher, F., Mayer, G., Perco, P., Mayer, B., Meyer, T.W., Oberbauer, R., Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 84 (2004), 353–361.
3. 3 Kainz, A., Wilflingseder, J., Mitterbauer, C., Haller, M., Burghuber, C., Perco, P., Langer, R.M., Heinze, G., Oberbauer, R., Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med 153 (2010), 222–230.
4. 4 Wilflingseder, J., Kainz, A., Muhlberger, I., Perco, P., Langer, R., Kristo, I., Mayer, B., Oberbauer, R., Impaired metabolism in donor kidney grafts after steroid pretreatment. Transpl Int 23 (2010), 796–804.
5. 5 Wilflingseder, J., Regele, H., Perco, P., Kainz, A., Soleiman, A., Muhlbacher, F., Mayer, B., Oberbauer, R., miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation 95 (2013), 835–841.
6. 6 El Sabbahy, M., Vaidya, V.S., Ischemic kidney injury and mechanisms of tissue repair. Wiley Interdiscip Rev Syst Biol Med 3 (2011), 606–618.
7. 7 Janssen, H.L., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A.J., Patick, A.K., Chen, A., Zhou, Y., Persson, R., King, B.D., Kauppinen, S., Levin, A.A., Hodges, M.R., Treatment of HCV infection by targeting microRNA. N Engl J Med 368 (2013), 1685–1694.
8. 8 Wilflingseder, J., Sunzenauer, J., Toronyi, E., Heinzel, A., Kainz, A., Mayer, B., Perco, P., Telkes, G., Langer, R.M., Oberbauer, R., Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles. PLoS One, 9, 2014, e104164.
9. 9 Oberbauer, R., Rohrmoser, M., Regele, H., Muhlbacher, F., Mayer, G., Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10 (1999), 2006–2013.
10. 10 Schwarz, C., Regele, H., Steininger, R., Hansmann, C., Mayer, G., Oberbauer, R., The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 71 (2001), 1666–1670.
11. 11 Oberbauer, R., Schwarz, C., Regele, H.M., Hansmann, C., Meyer, T.W., Mayer, G., Regulation of renal tubular cell apoptosis and proliferation after ischemic injury to a solitary kidney. J Lab Clin Med 138 (2001), 343–351.
12. 12 Stittrich, A.B., Haftmann, C., Sgouroudis, E., Kuhl, A.A., Hegazy, A.N., Panse, I., Riedel, R., Flossdorf, M., Dong, J., Fuhrmann, F., Heinz, G.A., Fang, Z., Li, N., Bissels, U., Hatam, F., Jahn, A., Hammoud, B., Matz, M., Schulze, F.M., Baumgrass, R., Bosio, A., Mollenkopf, H.J., Grun, J., Thiel, A., Chen, W., Hofer, T., Loddenkemper, C., Lohning, M., Chang, H.D., Rajewsky, N., Radbruch, A., Mashreghi, M.F., The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 11 (2010), 1057–1062.
13. 13 Solez, K., Colvin, R.B., Racusen, L.C., Haas, M., Sis, B., Mengel, M., Halloran, P.F., Baldwin, W., Banfi, G., Collins, A.B., Cosio, F., David, D.S., Drachenberg, C., Einecke, G., Fogo, A.B., Gibson, I.W., Glotz, D., Iskandar, S.S., Kraus, E., Lerut, E., Mannon, R.B., Mihatsch, M., Nankivell, B.J., Nickeleit, V., Papadimitriou, J.C., Randhawa, P., Regele, H., Renaudin, K., Roberts, I., Seron, D., Smith, R.N., Valente, M., Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8 (2008), 753–760.
14. 14 Gentleman, R., Carey, V., Huber, W., Irizarry, R., Dudoit, S., Bioinformatics and Computational Biology Solutions Using R Bioconductor. 2005, Springer Publications, New York, NY.
15. 15 Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., Speed, T.P., Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res, 31, 2003, e15.
16. 16 Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., Vlachos, I.S., Vergoulis, T., Reczko, M., Filippidis, C., Dalamagas, T., Hatzigeorgiou, A.G., DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res 41 (2013), W169–W173.
17. 17 Reczko, M., Maragkakis, M., Alexiou, P., Grosse, I., Hatzigeorgiou, A.G., Functional microRNA targets in protein coding sequences. Bioinformatics 28 (2012), 771–776.
18. 18 Enright, A.J., John, B., Gaul, U., Tuschl, T., Sander, C., Marks, D.S., MicroRNA targets in Drosophila. Genome Biol, 5, 2003, R1.
19. 19 Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19 (2009), 92–105.
20. 20 Chou, C.H., Chang, N.W., Shrestha, S., Hsu, S.D., Lin, Y.L., Lee, W.H., Yang, C.D., Hong, H.C., Wei, T.Y., Tu, S.J., Tsai, T.R., Ho, S.Y., Jian, T.Y., Wu, H.Y., Chen, P.R., Lin, N.C., Huang, H.T., Yang, T.L., Pai, C.Y., Tai, C.S., Chen, W.L., Huang, C.Y., Liu, C.C., Weng, S.L., Liao, K.W., Hsu, W.L., Huang, H.D., miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 44 (2016), D239–D247.
21. 21 Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 (2009), 44–57.
22. 22 Huang da, W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37 (2009), 1–13.
23. 23 Garcia, M.A., Meca, R., Leite, D., Boim, M.A., Effect of renal ischemia/reperfusion on gene expression of a pH-sensitive K+ channel. Nephron Physiol 106 (2007), p1–p7.
24. 24 Liu, J., Qin, J., Mei, W., Zhang, H., Yuan, Q., Peng, Z., Luo, R., Yuan, X., Huang, L., Tao, L., Expression of Niban in renal interstitial fibrosis. Nephrology (Carlton) 19 (2014), 479–489.
25. 25 Zhao, Y., Zhang, Y., Song, H.B., Wu, F., Wang, X.L., Sun, S.C., Cui, T.X., Tang, D.Q., Proteomic analysis revealed the altered kidney protein profile of a Cyld knockout mouse model. Genet Mol Res 14 (2015), 5970–5978.
26. 26 Ye, W., Zhang, L., Heme controls the expression of cell cycle regulators and cell growth in HeLa cells. Biochem Biophys Res Commun 315 (2004), 546–554.
27. 27 Suzuki, H., Kato, I., Usui, I., Takasaki, I., Tabuchi, Y., Oya, T., Tsuneyama, K., Kawaguchi, H., Hiraga, K., Takasawa, S., Okamoto, H., Tobe, K., Sasahara, M., Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice. Biochem Biophys Res Commun 379 (2009), 38–42.
28. 28 Lee, Y.J., Johnson, K.R., Hallenbeck, J.M., Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia. PLoS One, 7, 2012, e47787.
29. 29 Peng, X., Li, W., Yuan, L., Mehta, R.G., Kopelovich, L., McCormick, D.L., Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21. PLoS One, 8, 2013, e70442.
30. 30 Rihani, A., Van Goethem, A., Ongenaert, M., De Brouwer, S., Volders, P.J., Agarwal, S., De Preter, K., Mestdagh, P., Shohet, J., Speleman, F., Vandesompele, J., Van Maerken, T., Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma. Sci Rep, 5, 2015, 9027.
31. 31 Kabacik, S., Manning, G., Raffy, C., Bouffler, S., Badie, C., Time, dose and ataxia telangiectasia mutated (ATM) status dependency of coding and noncoding RNA expression after ionizing radiation exposure. Radiat Res 183 (2015), 325–337.
32. 32 Krishnan, K., Steptoe, A.L., Martin, H.C., Wani, S., Nones, K., Waddell, N., Mariasegaram, M., Simpson, P.T., Lakhani, S.R., Gabrielli, B., Vlassov, A., Cloonan, N., Grimmond, S.M., MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA 19 (2013), 230–242.
33. 33 Kouri, F.M., Hurley, L.A., Daniel, W.L., Day, E.S., Hua, Y., Hao, L., Peng, C.Y., Merkel, T.J., Queisser, M.A., Ritner, C., Zhang, H., James, C.D., Sznajder, J.I., Chin, L., Giljohann, D.A., Kessler, J.A., Peter, M.E., Mirkin, C.A., Stegh, A.H., miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev 29 (2015), 732–745.
34. 34 Stenvang, J., Petri, A., Lindow, M., Obad, S., Kauppinen, S., Inhibition of microRNA function by antimiR oligonucleotides. Silence, 3, 2012, 1.
35. 35 Bader, A.G., Brown, D., Winkler, M., The promise of microRNA replacement therapy. Cancer Res 70 (2010), 7027–7030.
36. 36 Oberbauer, R., Schreiner, G.F., Biber, J., Murer, H., Meyer, T.W., In vivo suppression of the renal Na+/Pi cotransporter by antisense oligonucleotides. Proc Natl Acad Sci U S A 93 (1996), 4903–4906.
37. 37 Lorenzen, J.M., Kaucsar, T., Schauerte, C., Schmitt, R., Rong, S., Hubner, A., Scherf, K., Fiedler, J., Martino, F., Kumarswamy, R., Kolling, M., Sorensen, I., Hinz, H., Heineke, J., van Rooij, E., Haller, H., Thum, T., MicroRNA-24 antagonism prevents renal ischemia reperfusion injury. J Am Soc Nephrol 25 (2014), 2717–2729.
38. 38 Molitoris, B.A., Dagher, P.C., Sandoval, R.M., Campos, S.B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S.J., Thompson, J.D., Kalinski, H., Skaliter, R., Erlich, S., Feinstein, E., siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20 (2009), 1754–1764.
39. 39 Singaravelu, K., Padanilam, B.J., p53 target Siva regulates apoptosis in ischemic kidneys. Am J Physiol Renal Physiol 300 (2011), F1130–F1141.
40. 40 Bijkerk, R., van Solingen, C., de Boer, H.C., van der Pol, P., de Bruin, R.G., van Oeveren-Rietdijk, A.M., Lievers, E., Schlagwein, N., van Gijlswijk, D.J., Roeten, M.K., Neshati, Z., de Vries, A.A., Rodijk, M., Pike-Overzet, K., van den Berg, Y.W., van der Veer, E.P., Versteeg, H.H., Reinders, M.E., Staal, F.J., van Kooten, C., Rabelink, T.J., van Zonneveld, A.J., Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. J Am Soc Nephrol 25 (2014), 1710–1722.
41. 41 Bhatt, K., Zhou, L., Mi, Q.S., Huang, S., She, J.X., Dong, Z., MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med 16 (2010), 409–416.